Medicine

All Articles

Human episodes of a novel reassortant Oropouche infection in the Brazilian Amazon.com location

.Attributes Medication, Posted online: 18 September 2024 doi:10.1038/ s41591-024-03300-3Genomic and ...

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative bosom cancer: a phase 2 adaptive test

.PatientsPatients in pals An and B were entitled for application if they went to the very least 18 y...

Targeted treatment guided through distributing tumor DNA evaluation in state-of-the-art gastrointestinal growths

.Attributes Medicine, Posted online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observa...

Countering the effect of the weather crisis on health and wellness are going to call for data

.As dramatically increasing global temperatures threaten the health and well-being of populations, s...

Exposure to extreme warmth boosts perinatal death in sub-Saharan Africa

.Publisheru00e2 $ s note Springer Attribute continues to be neutral with regard to managerial cases ...

Data- driven threat stratification as well as accuracy monitoring of pulmonary nodules sensed on breast computed tomography

.Attendee recruitmentThe retrospective key dataset comprised individuals coming from the MCC in the ...

Datopotamab\u00e2 $ \"deruxtecan in early-stage bosom cancer cells: the sequential numerous job randomized I-SPY2.2 period 2 trial

.Completing passions.J.L.M. mentions institutional analysis funding coming from AstraZeneca, Seagen,...

Trastuzumab deruxtecan in HER2-positive enhanced breast cancer cells with or even without brain metastases: a phase 3b\/4 test

.Nature Medication, Posted online: thirteen September 2024 doi:10.1038/ s41591-024-03261-7In the non...

Accelerating ASO therapies from growth to application

.Competing rate of interests.R.S., M.S., H.G. and also A.A.R. are organizers of the 1M1M project. H....

Post- commendation proof creation: a mutual accountability for medical care

.Mother Nature Medicine, Released online: 13 September 2024 doi:10.1038/ s41591-024-03241-xPost-appr...